A detailed history of Claret Asset Management Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Claret Asset Management Corp holds 8,045 shares of MRK stock, worth $914,636. This represents 0.18% of its overall portfolio holdings.

Number of Shares
8,045
Previous 7,838 2.64%
Holding current value
$914,636
Previous $1.03 Million 3.68%
% of portfolio
0.18%
Previous 0.17%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $25,626 - $27,522
207 Added 2.64%
8,045 $996,000
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $2,504 - $2,725
-25 Reduced 0.32%
7,838 $854,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $1,544 - $1,714
15 Added 0.19%
7,863 $809,000
Q2 2023

Aug 09, 2023

BUY
$108.61 - $118.38 $8,145 - $8,878
75 Added 0.96%
7,848 $906,000
Q1 2023

Apr 18, 2023

SELL
$102.94 - $114.86 $10,294 - $11,486
-100 Reduced 1.27%
7,773 $827,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $1,690 - $1,899
-20 Reduced 0.25%
7,873 $678,000
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $1,168 - $1,324
14 Added 0.18%
7,893 $720,000
Q1 2022

Apr 04, 2022

SELL
$73.51 - $82.4 $735 - $824
-10 Reduced 0.13%
7,879 $646,000
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $2,602 - $3,259
-36 Reduced 0.45%
7,889 $605,000
Q3 2021

Dec 02, 2021

BUY
$71.68 - $78.83 $1,433 - $1,576
20 Added 0.25%
7,925 $595,000
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $11,390 - $12,598
-162 Reduced 2.01%
7,905 $615,000
Q1 2021

May 04, 2021

SELL
$68.86 - $81.11 $12,601 - $14,843
-183 Reduced 2.22%
8,067 $622,000
Q4 2020

Feb 02, 2021

SELL
$71.77 - $79.65 $5,741 - $6,372
-80 Reduced 0.96%
8,250 $675,000
Q3 2020

Oct 29, 2020

SELL
$73.18 - $82.95 $28,540 - $32,350
-390 Reduced 4.47%
8,330 $691,000
Q2 2020

Aug 06, 2020

SELL
$70.42 - $80.13 $29,505 - $33,574
-419 Reduced 4.58%
8,720 $674,000
Q1 2020

Apr 06, 2020

SELL
$63.36 - $87.82 $126 - $175
-2 Reduced 0.02%
9,139 $703,000
Q4 2019

Jan 07, 2020

SELL
$77.58 - $87.54 $4,499 - $5,077
-58 Reduced 0.63%
9,141 $831,000
Q1 2019

Apr 29, 2019

SELL
$69.58 - $79.36 $2,226 - $2,539
-32 Reduced 0.35%
9,199 $765,000
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $326 - $378
5 Added 0.05%
9,231 $705,000
Q3 2018

Oct 30, 2018

SELL
$57.69 - $67.84 $1,730 - $2,035
-30 Reduced 0.32%
9,226 $654,000
Q4 2017

Mar 27, 2018

BUY
$51.62 - $61.64 $477,794 - $570,539
9,256
9,256 $521,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.